A panel of experts from Japan’s Ministry of Health approved the drug “Baricitinib” for the treatment of Covid-19


0
1 share

In Japan, the rheumatic arthritis drug “Baricitinib”, produced by a US pharmaceutical company, has been approved for use in the treatment of coronavirus.

A panel of experts from Japans Ministry of Health approved the drug Baricitinib for the treatment of Covid 19

Japan’s Ministry of Health, Labor and Welfare’s expert panel approved the use of the rheumatic arthritis drug “Baricitinib” pills in the treatment of a new type of coronavirus (Covid-19).

The pills “Baricitinib”, a rheumatic arthritis drug produced by Eli Lily of the United States, were approved by the expert health committee within the ministry, Kyodo reported.

The company applied to the ministry for approval of the drug in December. The ministry is expected to formally approve the use of the drug within a month.

“Baricitinib” was approved in the U.S. to be used in addition to the anti-viral drug “Remdesivir” in the treatment of Covid-19 patients who need oxygen supplements.

The Japanese government has so far approved the drugs “Remdesivir” and “steroid dexamethasone” in the treatment of Covid-19.

See also  Japan took the agenda: 4 days work 3 days vacation!

Like it? Share with your friends!

0
1 share

What's Your Reaction?

hate hate
0
hate
confused confused
0
confused
fail fail
0
fail
fun fun
0
fun
geeky geeky
0
geeky
love love
0
love
lol lol
0
lol
omg omg
0
omg
win win
0
win
Becks

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x